Haemato-Onkologie /ID# 221061

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Myeloproliferative neoplasms

Closed trials

• Completed

  Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

  NCT04472598· Phase 3· AbbVie· Source